ID
int64 1
9.11k
| age
float64 18
102
| death
int64 0
1
| sex
stringclasses 2
values | hospdead
int64 0
1
| slos
int64 3
343
| d.time
int64 3
2.03k
| dzgroup
stringclasses 8
values | dzclass
stringclasses 4
values | num.co
int64 0
9
| edu
float64 0
31
⌀ | income
stringclasses 4
values | scoma
float64 0
100
⌀ | charges
float64 1.17k
1.44M
⌀ | totcst
float64 0
633k
⌀ | totmcst
float64 -102.72
711k
⌀ | avtisst
float64 1
83
⌀ | race
stringclasses 5
values | sps
float64 0.2
99.2
⌀ | aps
float64 0
143
⌀ | surv2m
float64 0
0.97
⌀ | surv6m
float64 0
0.95
⌀ | hday
int64 1
148
| diabetes
int64 0
1
| dementia
int64 0
1
| ca
stringclasses 3
values | prg2m
float64 0
1
⌀ | prg6m
float64 0
1
⌀ | dnr
stringclasses 3
values | dnrday
float64 -88
285
⌀ | meanbp
float64 0
195
⌀ | wblc
float64 0
200
⌀ | hrt
float64 0
300
⌀ | resp
float64 0
90
⌀ | temp
float64 31.7
41.7
⌀ | pafi
float64 12
890
⌀ | alb
float64 0.4
29
⌀ | bili
float64 0.1
63
⌀ | crea
float64 0.1
21.5
⌀ | sod
float64 110
181
⌀ | ph
float64 6.83
7.77
⌀ | glucose
float64 0
1.09k
⌀ | bun
float64 1
300
⌀ | urine
float64 0
9k
⌀ | adlp
float64 0
7
⌀ | adls
float64 0
7
⌀ | sfdm2
stringclasses 5
values | adlsc
float64 0
7.07
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1
| 62.84998
| 0
|
male
| 0
| 5
| 2,029
|
Lung Cancer
|
Cancer
| 0
| 11
|
$11-$25k
| 0
| 9,715
| null | null | 7
|
other
| 33.898438
| 20
| 0.262939
| 0.036995
| 1
| 0
| 0
|
metastatic
| 0.5
| 0.25
|
no dnr
| 5
| 97
| 6
| 69
| 22
| 36
| 388
| 1.799805
| 0.199982
| 1.199951
| 141
| 7.459961
| null | null | null | 7
| 7
| null | 7
|
2
| 60.33899
| 1
|
female
| 1
| 4
| 4
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 2
| 12
|
$11-$25k
| 44
| 34,496
| null | null | 29
|
white
| 52.695313
| 74
| 0.001
| 0
| 3
| 0
| 0
|
no
| 0
| 0
| null | null | 43
| 17.097656
| 112
| 34
| 34.59375
| 98
| null | null | 5.5
| 132
| 7.25
| null | null | null | null | 1
|
<2 mo. follow-up
| 1
|
3
| 52.74698
| 1
|
female
| 0
| 17
| 47
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 2
| 12
|
under $11k
| 0
| 41,094
| null | null | 13
|
white
| 20.5
| 45
| 0.790894
| 0.664917
| 4
| 0
| 0
|
no
| 0.75
| 0.5
|
no dnr
| 17
| 70
| 8.5
| 88
| 28
| 37.39844
| 231.65625
| null | 2.199707
| 2
| 134
| 7.459961
| null | null | null | 1
| 0
|
<2 mo. follow-up
| 0
|
4
| 42.38498
| 1
|
female
| 0
| 3
| 133
|
Lung Cancer
|
Cancer
| 2
| 11
|
under $11k
| 0
| 3,075
| null | null | 7
|
white
| 20.097656
| 19
| 0.698975
| 0.411987
| 1
| 0
| 0
|
metastatic
| 0.9
| 0.5
|
no dnr
| 3
| 75
| 9.099609
| 88
| 32
| 35
| null | null | null | 0.799927
| 139
| null | null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
|
5
| 79.88495
| 0
|
female
| 0
| 16
| 2,029
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null | null | 26
| 50,127
| null | null | 18.666656
|
white
| 23.5
| 30
| 0.634888
| 0.532959
| 3
| 0
| 0
|
no
| 0.9
| 0.9
|
no dnr
| 16
| 59
| 13.5
| 112
| 20
| 37.89844
| 173.3125
| null | null | 0.799927
| 143
| 7.509766
| null | null | null | null | 2
|
no(M2 and SIP pres)
| 2
|
6
| 93.01599
| 1
|
male
| 1
| 4
| 4
|
Coma
|
Coma
| 1
| 14
| null | 55
| 6,884
| null | null | 5
|
white
| 19.398438
| 27
| 0.284973
| 0.214996
| 1
| 0
| 0
|
no
| 0
| 0
|
no dnr
| 4
| 110
| 10.398438
| 101
| 44
| 38.39844
| 266.625
| null | null | 0.699951
| 140
| 7.65918
| null | null | null | null | 1
|
<2 mo. follow-up
| 1
|
7
| 62.37097
| 1
|
male
| 0
| 9
| 659
|
CHF
|
COPD/CHF/Cirrhosis
| 1
| 14
|
$25-$50k
| 0
| 30,460
| null | null | 8
|
white
| 17.296875
| 46
| 0.892944
| 0.820923
| 1
| 0
| 0
|
no
| null | 0.7
|
no dnr
| 9
| 78
| 11.699219
| 120
| 28
| 37.39844
| 309.5
| 4.799805
| 0.399963
| 1.599854
| 132
| 7.479492
| null | null | null | 0
| 1
|
no(M2 and SIP pres)
| 1
|
8
| 86.83899
| 1
|
male
| 0
| 7
| 142
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| null | null | 26
| 30,460
| null | null | 6.5
|
white
| 21.597656
| 53
| 0.670898
| 0.498962
| 1
| 1
| 0
|
no
| 0.8
| 0.4
|
no dnr
| 7
| 72
| 13.599609
| 100
| 26
| 37.59375
| 404.75
| null | null | 2
| 139
| 7.509766
| null | null | null | null | 0
| null | 0
|
9
| 85.65594
| 1
|
male
| 0
| 12
| 63
|
Lung Cancer
|
Cancer
| 2
| 12
| null | 26
| null | null | null | 8.5
|
black
| 15.898438
| 17
| 0.570923
| 0.248993
| 1
| 0
| 1
|
metastatic
| 0.05
| 0.000125
|
dnr after sadm
| 2
| 97
| 9.699219
| 56
| 20
| 36.59375
| 357.125
| null | 0.399963
| 1
| 143
| 7.449219
| null | null | null | null | 7
| null | 7
|
10
| 42.25897
| 1
|
female
| 0
| 8
| 370
|
Colon Cancer
|
Cancer
| 0
| 11
|
$25-$50k
| 0
| 9,914
| null | null | 8
|
hispanic
| 2.299805
| 9
| 0.952881
| 0.887939
| 1
| 0
| 0
|
metastatic
| null | null |
no dnr
| 8
| 84
| 11.298828
| 94
| 20
| 38.19531
| null | 4.699219
| 0.199982
| 0.799927
| 139
| null | null | null | null | 0
| null | null | 0.4948
|
11
| 47.94498
| 1
|
male
| 0
| 7
| 114
|
CHF
|
COPD/CHF/Cirrhosis
| 1
| 12
| null | 0
| 15,558
| null | null | 12.5
|
white
| 14.599609
| 14
| 0.935913
| 0.890991
| 1
| 0
| 0
|
no
| 0.7
| 0.5
|
no dnr
| 7
| 70
| 10.898438
| 105
| 24
| 36.5
| null | 4.199219
| 0.5
| 1
| 134
| null | null | null | null | 2
| 1
|
no(M2 and SIP pres)
| 1
|
12
| 59.20099
| 1
|
male
| 1
| 13
| 13
|
Lung Cancer
|
Cancer
| 0
| 14
| null | 0
| 29,388
| null | null | 8
|
white
| 16.398438
| 17
| 0.731934
| 0.461975
| 1
| 0
| 0
|
metastatic
| null | null |
dnr after sadm
| 12
| 77
| 10.798828
| 90
| 22
| 36.39844
| null | null | null | 1.099854
| 136
| null | null | null | null | 1
| 1
|
<2 mo. follow-up
| 1
|
13
| 29.002
| 1
|
female
| 0
| 4
| 160
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 1
| 16
|
$11-$25k
| 0
| 4,353
| null | null | 8
|
white
| 26.898438
| 30
| 0.850952
| 0.754883
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 4
| 56
| 5.5
| 56
| 20
| 37.19531
| null | 2.899902
| 6.099609
| 0.699951
| 130
| null | null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
|
14
| 68.14197
| 1
|
male
| 0
| 8
| 1,866
|
CHF
|
COPD/CHF/Cirrhosis
| 0
| 12
|
$11-$25k
| 0
| 19,783
| null | null | 16
|
white
| 20.296875
| 34
| 0.849976
| 0.75293
| 1
| 0
| 0
|
no
| 0.9
| 0.7
|
no dnr
| 8
| 68
| 9.398438
| 80
| 22
| 36
| null | null | 0.599976
| 2.599609
| 139
| null | null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
|
15
| 43.53998
| 0
|
female
| 0
| 115
| 2,022
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null | null | 26
| 706,577
| 390,460.5
| null | 38.25
|
white
| 30.5
| 39
| 0.590942
| 0.481995
| 148
| 0
| 0
|
no
| 0.9
| 0.9
|
no dnr
| 115
| 67
| 24.597656
| 172
| 20
| 38.79688
| 113.32812
| null | null | 0.599976
| 134
| 7.399414
| null | null | null | null | null |
SIP>=30
| 2.76416
|
16
| 58.823
| 1
|
female
| 0
| 7
| 503
|
Lung Cancer
|
Cancer
| 1
| 12
|
>$50k
| 0
| 10,758
| null | null | 10
|
white
| 7.799805
| 11
| 0.856934
| 0.682983
| 1
| 0
| 0
|
metastatic
| 0.9
| 0.7
|
no dnr
| 7
| 97
| 15.898438
| 92
| 20
| 37.19531
| null | 4.299805
| 0.199982
| 0.799927
| 134
| null | null | null | null | 2
| 0
| null | 0
|
17
| 45.418
| 1
|
male
| 0
| 7
| 827
|
Lung Cancer
|
Cancer
| 2
| null | null | 0
| 8,400
| null | null | 7
|
white
| 16
| 4
| 0.768921
| 0.521973
| 1
| 0
| 0
|
metastatic
| null | null |
no dnr
| 7
| 97
| 10.798828
| 100
| 24
| 37.29688
| 585.125
| null | 0.299988
| 1.099854
| 137
| 7.489258
| null | null | null | null | null | null | 3.351563
|
18
| 63.66299
| 1
|
female
| 1
| 14
| 14
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 22
|
$25-$50k
| 26
| 283,303
| 156,674.125
| null | 40
|
white
| 40.296875
| 58
| 0.212982
| 0.116989
| 13
| 0
| 0
|
no
| 0.1
| 0.001
|
dnr after sadm
| 12
| 69
| 30.097656
| 108
| 22
| 36.69531
| 155.53125
| 2.899902
| 14
| 2.899902
| 130
| 7.449219
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
|
19
| 31.84399
| 1
|
male
| 1
| 15
| 15
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 2
| 16
|
under $11k
| 0
| 27,985
| 17,528.4375
| null | 10
|
white
| 33.898438
| 42
| 0.73291
| 0.581909
| 1
| 0
| 0
|
no
| null | null |
dnr after sadm
| 12
| 83
| 5
| 100
| 24
| 37.39844
| null | 1.699951
| 12.798828
| 0.299988
| 122
| null | null | null | null | 7
| 7
|
<2 mo. follow-up
| 7
|
20
| 55.13797
| 1
|
male
| 0
| 10
| 179
|
CHF
|
COPD/CHF/Cirrhosis
| 1
| 8
|
$11-$25k
| 0
| 18,191
| null | null | 14.5
|
hispanic
| 17.699219
| 25
| 0.904907
| 0.840942
| 1
| 0
| 0
|
no
| 0.5
| 0.5
|
no dnr
| 10
| 78
| null | 72
| 20
| 36
| null | null | null | 1.5
| 134
| null | null | null | null | 3
| null |
no(M2 and SIP pres)
| 2.511099
|
21
| 68.25494
| 1
|
male
| 0
| 7
| 227
|
Lung Cancer
|
Cancer
| 0
| 13
|
>$50k
| 0
| 10,755
| null | null | 8
|
white
| 5.599609
| 16
| 0.868896
| 0.704956
| 1
| 0
| 0
|
metastatic
| 0.9
| 0.7
|
no dnr
| 7
| 91
| 5
| 92
| 20
| 36.5
| null | 4.299805
| 0.299988
| 1.199951
| 138
| null | null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
|
22
| 48.70398
| 1
|
male
| 0
| 23
| 30
|
Lung Cancer
|
Cancer
| 0
| 16
| null | 0
| 55,384
| 33,002.5
| null | 9.666664
|
other
| 26.199219
| 35
| 0.535889
| 0.213989
| 1
| 0
| 0
|
metastatic
| 0.5
| 0.125
|
dnr after sadm
| 11
| 66
| 12.5
| 125
| 30
| 37
| 170
| null | null | 1
| 133
| 7.519531
| null | null | null | null | null |
<2 mo. follow-up
| 3.263672
|
23
| 49.61298
| 0
|
female
| 0
| 50
| 2,019
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
|
$25-$50k
| 0
| 542,266
| 288,592.25
| null | 33.75
|
white
| 31.699219
| 42
| 0.650879
| 0.55188
| 29
| 0
| 0
|
no
| 0.6
| 0.5
|
no dnr
| 50
| 67
| 11
| 120
| 48
| 38.89844
| 200
| 2
| 4.099609
| 0.599976
| 130
| 7.399414
| null | null | null | null | 5
|
adl>=4 (>=5 if sur)
| 5
|
24
| 50.724
| 1
|
female
| 0
| 3
| 817
|
Lung Cancer
|
Cancer
| 0
| 12
|
$25-$50k
| 0
| 4,913
| null | null | 10
|
asian
| 14.199219
| 11
| 0.786987
| 0.552979
| 1
| 0
| 0
|
metastatic
| 1
| 1
|
no dnr
| 3
| 71
| 9.798828
| 88
| 24
| 37.39844
| null | null | null | 0.899902
| 141
| null | null | null | null | null | null |
no(M2 and SIP pres)
| 2.065918
|
25
| 29.36099
| 1
|
female
| 0
| 4
| 399
|
Colon Cancer
|
Cancer
| 0
| 17
|
$25-$50k
| 0
| 7,792
| null | null | 13
|
white
| 18.898438
| 10
| 0.853882
| 0.674927
| 1
| 0
| 0
|
metastatic
| 0.5
| 0.1
|
no dnr
| 4
| 96
| 10.599609
| 112
| 20
| 37
| null | 3.699707
| 1.399902
| 0.599976
| 137
| null | null | null | null | null | null |
no(M2 and SIP pres)
| 1.814941
|
26
| 53.84
| 1
|
male
| 0
| 7
| 1,064
|
COPD
|
COPD/CHF/Cirrhosis
| 1
| null |
under $11k
| 0
| 9,871
| 6,112.4609
| null | 8
|
white
| 14.199219
| 16
| 0.939941
| 0.897949
| 1
| 0
| 0
|
no
| 0.9
| 0.6
|
dnr after sadm
| 4
| 134
| 7.799805
| 106
| 22
| 37.89844
| 304.125
| 3.799805
| 0.5
| 0.799927
| 141
| 7.379883
| null | null | null | 5
| 4
|
no(M2 and SIP pres)
| 4
|
27
| 82.41498
| 1
|
female
| 1
| 5
| 5
|
Lung Cancer
|
Cancer
| 0
| null | null | 44
| 7,212
| null | null | 9
|
white
| 27.296875
| 33
| 0.169983
| 0.011999
| 1
| 0
| 0
|
metastatic
| null | null |
dnr before sadm
| -1
| 75
| 6.799805
| 114
| 20
| 37.19531
| null | 3.099609
| null | 1.799805
| 131
| null | null | null | null | null | null |
<2 mo. follow-up
| 3.704102
|
28
| 27.32399
| 1
|
male
| 1
| 7
| 7
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 19
| null | 26
| 160,060
| 82,131.25
| null | 39
|
asian
| 46.796875
| 85
| 0.021
| 0.004999
| 28
| 0
| 0
|
yes
| 0.05
| 0.000125
|
dnr after sadm
| 5
| 77
| 0.099991
| 144
| 36
| 38.89844
| 45
| 2.399902
| 5
| 1.399902
| 147
| 7.30957
| null | null | null | null | 2
|
<2 mo. follow-up
| 2
|
29
| 30.10799
| 0
|
male
| 0
| 10
| 2,013
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| null | null | 37
| 57,611
| 29,342.3906
| null | 30.5
|
asian
| 22.398438
| 21
| 0.823975
| 0.764893
| 4
| 0
| 0
|
no
| null | null |
no dnr
| 10
| 92
| 8.798828
| 112
| 27
| 37.59375
| 225
| null | null | 0.399963
| 134
| 7.459961
| null | null | null | null | null | null | 2.846191
|
30
| 50.37097
| 0
|
male
| 0
| 105
| 2,013
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 2
| 16
|
$11-$25k
| 0
| 465,380
| 304,749.25
| null | 22.25
|
white
| 21.296875
| 18
| 0.80896
| 0.690918
| 2
| 0
| 0
|
no
| null | null |
no dnr
| 105
| 98
| 8.398438
| 82
| 20
| 37.39844
| 197.5
| 3
| 6.799805
| 0.699951
| 138
| 7.319336
| null | null | null | 3
| 1
|
SIP>=30
| 1
|
31
| 74.48297
| 0
|
male
| 0
| 15
| 2,012
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 16
|
>$50k
| 0
| 18,134
| 12,751.7344
| null | 7.666664
|
white
| 16.296875
| 27
| 0.872925
| 0.787964
| 1
| 0
| 0
|
no
| 0.95
| 0.6
|
no dnr
| 15
| 111
| 6.899414
| 60
| 32
| 36.79688
| null | 3.799805
| 0.599976
| 1.599854
| 142
| null | null | null | null | 0
| 1
| null | 1
|
32
| 55.73199
| 0
|
male
| 0
| 13
| 2,012
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 2
| 8
|
under $11k
| 0
| 52,092
| 28,262.7031
| null | 17
|
hispanic
| 31
| 25
| 0.602905
| 0.41394
| 1
| 0
| 0
|
no
| 0.9
| 0.9
|
no dnr
| 13
| 121
| 19.699219
| 118
| 18
| 37.39844
| 404.75
| 2.199707
| 0.899902
| 0.799927
| 117
| 7.379883
| null | null | null | 7
| 6
|
SIP>=30
| 6
|
33
| 77.21295
| 1
|
female
| 0
| 7
| 51
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 0
| null | 0
| 9,078
| 6,898.4922
| null | 12
|
hispanic
| 21.796875
| 39
| 0.773926
| 0.638916
| 1
| 0
| 0
|
no
| 0.75
| 0.75
|
dnr after sadm
| 2
| 113
| 8.298828
| 93
| 25
| 36.19531
| 250
| null | null | 2.099609
| 145
| 7.269531
| null | null | null | null | 7
|
<2 mo. follow-up
| 7
|
34
| 61.02399
| 1
|
female
| 1
| 20
| 20
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null | null | 37
| 109,627
| 57,442.7812
| null | 30.333328
|
white
| 26
| 49
| 0.67395
| 0.577881
| 1
| 0
| 0
|
no
| 0.6
| 0.6
|
dnr after sadm
| 17
| 80
| 15.398438
| 128
| 30
| 38.5
| 217.5
| 2.299805
| 0.399963
| 2.399902
| 143
| 7.329102
| null | null | null | null | null |
<2 mo. follow-up
| 2.825195
|
35
| 56.48999
| 1
|
female
| 0
| 5
| 113
|
CHF
|
COPD/CHF/Cirrhosis
| 1
| 12
| null | 0
| 38,548
| 20,959.2031
| null | 16
|
hispanic
| 37.398438
| 53
| 0.546997
| 0.348999
| 4
| 0
| 0
|
no
| null | null |
no dnr
| 5
| 38
| null | 92
| 20
| 36
| null | null | null | 6
| 133
| null | null | null | null | null | null | null | 3.098145
|
36
| 57.53299
| 0
|
female
| 0
| 28
| 2,010
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 1
| 14
|
under $11k
| 0
| 156,556
| 103,090.438
| null | 14.5
|
hispanic
| 26.597656
| 37
| 0.688965
| 0.522949
| 1
| 0
| 0
|
no
| 0.7
| 0.5
|
no dnr
| 28
| 77
| 12.199219
| 92
| 18
| 37.59375
| 552.375
| 2.5
| 23.597656
| 0.899902
| 132
| 7.439453
| null | null | null | null | null |
no(M2 and SIP pres)
| 3.131836
|
37
| 68.98596
| 1
|
female
| 0
| 4
| 603
|
COPD
|
COPD/CHF/Cirrhosis
| 1
| 10
|
under $11k
| 0
| 5,763
| 2,965.9512
| null | 3
|
white
| 12.798828
| 21
| 0.910889
| 0.849976
| 1
| 0
| 0
|
no
| 0.99
| 0.95
|
no dnr
| 4
| 76
| null | 78
| 26
| 36.59375
| 280.9375
| 4
| null | 0.799927
| 142
| 7.359375
| null | null | null | 1
| 0
|
SIP>=30
| 0
|
38
| 41.97897
| 1
|
male
| 0
| 6
| 518
|
CHF
|
COPD/CHF/Cirrhosis
| 1
| 14
|
$11-$25k
| 0
| 5,552
| 3,679.8398
| null | 12
|
white
| 19.5
| 37
| 0.917969
| 0.860962
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 6
| 120
| 8.398438
| 86
| 22
| 37.5
| 295.1875
| null | null | 1.799805
| 129
| 7.5
| null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
|
39
| 19.79199
| 0
|
male
| 0
| 33
| 2,008
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
|
under $11k
| 0
| 167,971
| null | null | 21.25
|
black
| 18.699219
| 5
| 0.932983
| 0.908936
| 4
| 0
| 0
|
no
| 0.9
| 0.75
|
no dnr
| 33
| 83
| 9.599609
| 52
| 6
| 39
| 310
| null | null | null | 131
| 7.439453
| null | null | null | null | 0
|
adl>=4 (>=5 if sur)
| 0
|
40
| 57.50897
| 1
|
female
| 0
| 4
| 841
|
CHF
|
COPD/CHF/Cirrhosis
| 0
| 14
|
under $11k
| 0
| 6,403
| 3,672.0723
| null | 11
|
black
| 23.199219
| 27
| 0.849976
| 0.75293
| 1
| 0
| 0
|
no
| 1
| 1
|
no dnr
| 4
| 83
| 14.298828
| 106
| 24
| 36.79688
| 280.9375
| null | null | 2.299805
| 138
| 7.449219
| null | null | null | 5
| 6
|
SIP>=30
| 6
|
41
| 73.40698
| 0
|
male
| 0
| 9
| 2,007
|
Colon Cancer
|
Cancer
| 1
| null | null | 0
| 22,934
| 14,292.2656
| null | 12.5
|
white
| 11.599609
| 23
| 0.866943
| 0.701904
| 1
| 0
| 0
|
metastatic
| 0.9
| 0.4
|
no dnr
| 9
| 71
| 16.5
| 76
| 10
| 37
| null | 4
| 0.599976
| 0.799927
| 141
| null | null | null | null | null | null | null | 2.467773
|
42
| 68.31799
| 1
|
male
| 0
| 6
| 172
|
Colon Cancer
|
Cancer
| 1
| 21
|
>$50k
| 0
| 9,205
| 5,793.1914
| null | 11
|
white
| 14.898438
| 8
| 0.838989
| 0.645996
| 1
| 0
| 0
|
metastatic
| null | null |
no dnr
| 6
| 89
| 10.599609
| 92
| 18
| 39
| null | null | 0.5
| 1
| 136
| null | null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
|
43
| 75.79498
| 1
|
female
| 1
| 23
| 23
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null | null | 0
| 271,250
| 136,387.875
| null | 42.333313
|
white
| 40
| 76
| 0.283997
| 0.174988
| 8
| 0
| 0
|
no
| null | null |
dnr after sadm
| 21
| 59
| 30.597656
| 90
| 22
| 37.5
| 70.90625
| 1.899902
| 5.399414
| 2.699707
| 128
| 7.329102
| null | null | null | null | null |
<2 mo. follow-up
| 2.685547
|
44
| 45.71899
| 0
|
male
| 0
| 20
| 2,006
|
CHF
|
COPD/CHF/Cirrhosis
| 1
| 12
| null | 0
| 115,112
| 61,771.0625
| null | 25.666656
|
white
| 21.796875
| 30
| 0.893921
| 0.821899
| 1
| 0
| 0
|
no
| 0.9
| 0.5
|
no dnr
| 20
| 57
| 12.298828
| 96
| 22
| 36
| 185
| 3.899902
| null | 1.399902
| 135
| 7.599609
| null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
|
45
| 75.48798
| 1
|
male
| 0
| 36
| 79
|
CHF
|
COPD/CHF/Cirrhosis
| 1
| 16
|
under $11k
| 0
| 120,920
| 64,202.375
| null | 23.25
|
hispanic
| 32.296875
| 39
| 0.601929
| 0.412964
| 1
| 0
| 0
|
no
| 0.5
| 0.5
|
dnr after sadm
| 16
| 62
| 21.796875
| 102
| 24
| 36.59375
| 415
| null | null | 4
| 124
| 7.429688
| null | null | null | 2
| 0
| null | 0
|
46
| 74.995
| 1
|
female
| 1
| 25
| 25
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| null | null | 0
| 348,931
| 173,763.5
| null | 43
|
white
| 35.695313
| 53
| 0.41095
| 0.290955
| 10
| 0
| 0
|
no
| null | null |
dnr after sadm
| 23
| 50
| 51.195313
| 120
| 18
| 36.19531
| 237.5
| 2.899902
| 1
| 4.799805
| 135
| 7.439453
| null | null | null | null | null |
<2 mo. follow-up
| 2.442383
|
47
| 56.19397
| 1
|
male
| 1
| 21
| 21
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 6
| null | 26
| 230,733
| 119,196
| null | 41.333313
|
other
| 36.695313
| 70
| 0.362
| 0.243988
| 15
| 0
| 0
|
no
| null | null |
dnr after sadm
| 20
| 68
| 26.699219
| 130
| 28
| 38.5
| 121.65625
| 1.699951
| 3.899902
| 2.099609
| 131
| 7.449219
| null | null | null | null | 3
|
<2 mo. follow-up
| 3
|
48
| 44.849
| 1
|
female
| 0
| 12
| 229
|
MOSF w/Malig
|
ARF/MOSF
| 2
| 10
|
$11-$25k
| 0
| 25,176
| 12,210.7812
| null | 19.5
|
hispanic
| 24.796875
| 32
| 0.709961
| 0.620972
| 1
| 0
| 0
|
yes
| 0.6
| 0.4
|
no dnr
| 12
| 91
| 4.699219
| 70
| 32
| 37.09375
| 447.5625
| 2.299805
| 7
| 0.799927
| 136
| 7.359375
| null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
|
49
| 51.09698
| 1
|
female
| 0
| 19
| 489
|
CHF
|
COPD/CHF/Cirrhosis
| 1
| 11
| null | 0
| 30,877
| 17,287.9531
| null | 12
|
black
| 22.296875
| 43
| 0.876953
| 0.794922
| 1
| 0
| 0
|
no
| 0.95
| 0.95
|
no dnr
| 19
| 100
| 5.699219
| 120
| 32
| 37.59375
| 203.6875
| 4.199219
| 0.199982
| 4
| 140
| 7.459961
| null | null | null | 2
| null | null | 1.839
|
50
| 36.30899
| 1
|
male
| 0
| 11
| 653
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 16
| null | 0
| 23,476
| 14,620.8047
| null | 15.5
|
white
| 26.097656
| 31
| 0.878906
| 0.797974
| 1
| 0
| 0
|
no
| 0.6
| 0.5
|
no dnr
| 11
| 64
| 6.799805
| 115
| 20
| 36.29688
| null | 4.399414
| 4.5
| 1.299805
| 121
| null | null | null | null | 1
| 0
| null | 0
|
51
| 76.25696
| 0
|
male
| 0
| 9
| 2,001
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 12
| null | 0
| 14,926
| 8,138.4414
| null | 7.5
|
white
| 17.796875
| 32
| 0.852905
| 0.757935
| 1
| 0
| 0
|
no
| 0.9
| 0.75
|
no dnr
| 9
| 74
| 9.298828
| 96
| 30
| 36.39844
| 266.625
| null | 1.099854
| 1.199951
| 141
| 7.399414
| null | null | null | 1
| 2
| null | 2
|
52
| 51.30499
| 1
|
male
| 0
| 25
| 162
|
CHF
|
COPD/CHF/Cirrhosis
| 1
| 12
|
under $11k
| 0
| 52,187
| 30,876.375
| null | 11.75
|
black
| 26.097656
| 33
| 0.822998
| 0.711914
| 2
| 0
| 0
|
no
| 0.8
| 0.75
|
no dnr
| 25
| 71
| null | 104
| 18
| 36.5
| null | null | null | 2.399902
| 128
| null | null | null | null | 1
| 0
|
no(M2 and SIP pres)
| 0
|
53
| 74.54297
| 0
|
female
| 0
| 7
| 2,000
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 12
|
under $11k
| 0
| 9,631
| 5,835.1602
| null | 8
|
white
| 22
| 23
| 0.78894
| 0.660889
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 7
| 83
| 14.199219
| 92
| 22
| 36.39844
| 164
| 3.299805
| 0.299988
| 0.799927
| 137
| 7.449219
| null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
|
54
| 54.30798
| 1
|
male
| 0
| 12
| 536
|
Lung Cancer
|
Cancer
| 1
| 17
|
$25-$50k
| 0
| 29,939
| 17,625.75
| null | 14.5
|
white
| 20.898438
| 8
| 0.650879
| 0.345947
| 1
| 0
| 0
|
metastatic
| 1
| 1
|
no dnr
| 12
| 95
| 11.599609
| 108
| 22
| 38
| 183
| null | null | 0.799927
| 136
| 7.399414
| null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
|
55
| 77.57697
| 1
|
female
| 0
| 3
| 244
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| null | null | 0
| 3,124
| 2,022.1035
| null | 6
|
other
| 17.296875
| 27
| 0.853882
| 0.758911
| 1
| 1
| 0
|
no
| null | null |
no dnr
| 3
| 90
| 12.398438
| 84
| 32
| 36.59375
| 276.1875
| null | null | 0.799927
| 139
| 7.469727
| null | null | null | null | null | null | 2.308594
|
56
| 84.95795
| 0
|
male
| 0
| 17
| 1,998
|
CHF
|
COPD/CHF/Cirrhosis
| 4
| 14
|
>$50k
| 0
| 30,942
| 18,401.7188
| null | 8.666664
|
white
| 14.099609
| 21
| 0.865967
| 0.777954
| 1
| 0
| 0
|
no
| 0.95
| 0.85
|
no dnr
| 17
| 92
| 13.699219
| 80
| 32
| 37.19531
| 313.3125
| 3.799805
| 0.299988
| 1.299805
| 137
| 7.429688
| null | null | null | 0
| null |
no(M2 and SIP pres)
| 0.4948
|
57
| 41.52197
| 1
|
male
| 1
| 21
| 21
|
MOSF w/Malig
|
ARF/MOSF
| 2
| 18
|
>$50k
| 26
| 320,843
| 165,178.875
| null | 32.666657
|
white
| 36.09375
| 78
| 0.171997
| 0.08699
| 26
| 0
| 0
|
yes
| 0.1
| 0.001
|
no dnr
| 21
| 66
| 0.199982
| 130
| 18
| 37.5
| 315
| 1.899902
| 3.799805
| 7.299805
| 134
| 7.359375
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
|
58
| 39.685
| 0
|
female
| 0
| 35
| 1,995
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 22
|
$25-$50k
| 0
| 220,639
| 109,700.75
| null | 33
|
white
| 26
| 56
| 0.820923
| 0.759888
| 7
| 1
| 0
|
no
| 0.6
| 0.6
|
no dnr
| 35
| 62
| 36.695313
| 125
| 24
| 39.19531
| 208.5625
| 1.599854
| 0.399963
| 7.699219
| 139
| 7.399414
| null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
|
59
| 72.55896
| 1
|
female
| 1
| 4
| 4
|
COPD
|
COPD/CHF/Cirrhosis
| 3
| null | null | 0
| 4,894
| 3,078.6016
| null | 6
|
white
| 26
| 25
| 0.60791
| 0.419983
| 1
| 0
| 0
|
metastatic
| null | null |
dnr after sadm
| 1
| 123
| 13.298828
| 98
| 32
| 37.19531
| 144.875
| null | null | 0.5
| 136
| 7.339844
| null | null | null | null | null |
<2 mo. follow-up
| 3.955078
|
60
| 60.10098
| 1
|
male
| 0
| 15
| 195
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 1
| null | null | 0
| 63,466
| 32,079.9531
| null | 27.666656
|
white
| 22.597656
| 40
| 0.746948
| 0.601929
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 15
| 110
| 6.299805
| 125
| 10
| 38.09375
| 208
| 2.799805
| 3.399902
| 1
| 142
| 7.439453
| null | null | null | null | null | null | 2.381348
|
61
| 70.81195
| 0
|
male
| 0
| 8
| 1,992
|
CHF
|
COPD/CHF/Cirrhosis
| 1
| null | null | 0
| 6,254
| 4,126.0742
| null | 5
|
black
| 16.199219
| 20
| 0.882935
| 0.804932
| 1
| 0
| 0
|
no
| 0.9
| 0.8
|
no dnr
| 8
| 88
| 6.899414
| 80
| 22
| 37
| null | null | null | 1.799805
| 142
| null | null | null | null | null | null | null | 2.595703
|
62
| 30.76199
| 0
|
male
| 0
| 6
| 1,990
|
CHF
|
COPD/CHF/Cirrhosis
| 1
| 10
|
under $11k
| 0
| 8,437
| 5,632.8516
| null | 10
|
hispanic
| 24.5
| 37
| 0.903931
| 0.838989
| 1
| 0
| 0
|
no
| 0.8
| 0.7
|
no dnr
| 6
| 70
| 6.599609
| 122
| 16
| 36.5
| 528.5
| null | null | 2.099609
| 133
| 7.459961
| null | null | null | 0
| null |
no(M2 and SIP pres)
| 0.4948
|
63
| 64.23798
| 1
|
male
| 0
| 61
| 974
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
| null | 0
| 321,716
| 162,087.25
| null | 34.5
|
white
| 26
| 32
| 0.738892
| 0.657959
| 5
| 0
| 0
|
no
| 0.9
| 0.9
|
no dnr
| 61
| 68
| 9.5
| 122
| 12
| 38.69531
| 114
| null | null | 1.299805
| 136
| 7.319336
| null | null | null | null | 0
| null | 0
|
64
| 51.70999
| 0
|
male
| 0
| 12
| 1,987
|
CHF
|
COPD/CHF/Cirrhosis
| 1
| null | null | 0
| 31,222
| 18,348.2188
| null | 16
|
asian
| 18.796875
| 21
| 0.903931
| 0.838989
| 1
| 0
| 0
|
no
| 0.8
| 0.2
|
no dnr
| 12
| 50
| 6.699219
| 75
| 20
| 36.79688
| null | 3.699707
| null | 0.899902
| 138
| null | null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
|
65
| 64.64294
| 1
|
male
| 0
| 17
| 254
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 12
| null | 9
| 180,786
| 95,272.6875
| null | 25.333328
|
white
| 30.898438
| 49
| 0.554932
| 0.441956
| 17
| 1
| 0
|
no
| null | null |
no dnr
| 17
| 68
| 13.298828
| 92
| 38
| 38.79688
| 113.67188
| 3.399902
| 1.099854
| 2.299805
| 133
| 7.479492
| null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
|
66
| 69.41498
| 1
|
male
| 0
| 6
| 101
|
Lung Cancer
|
Cancer
| 2
| 16
|
$25-$50k
| 26
| 8,706
| 5,389.1289
| null | 8
|
white
| 25.5
| 11
| 0.352966
| 0.075989
| 1
| 0
| 1
|
metastatic
| null | null |
dnr after sadm
| 2
| 109
| 5.299805
| 68
| 20
| 36.89844
| null | 2.699707
| null | 0.699951
| 133
| null | null | null | null | null | 2
|
adl>=4 (>=5 if sur)
| 2
|
67
| 57.19098
| 1
|
male
| 0
| 9
| 42
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 12
|
$11-$25k
| 0
| 28,476
| 17,331.0938
| null | 18
|
white
| 24.398438
| 42
| 0.836914
| 0.73291
| 1
| 0
| 0
|
no
| 0.3
| 0.1
|
no dnr
| 9
| 59
| 16
| 85
| 26
| 36.79688
| 204.75
| null | 0.5
| 0.799927
| 126
| 7.449219
| null | null | null | 0
| null |
<2 mo. follow-up
| 0.4948
|
68
| 37.73297
| 1
|
male
| 0
| 9
| 20
|
CHF
|
COPD/CHF/Cirrhosis
| 1
| 12
|
$25-$50k
| 0
| 26,278
| 14,961.0938
| null | 19
|
white
| 24.199219
| 23
| 0.891968
| 0.81897
| 1
| 0
| 0
|
no
| 0.2
| 0.05
|
no dnr
| 9
| 67
| 7.5
| 130
| 16
| 36.5
| 347.5625
| 3
| 0.599976
| 0.899902
| 132
| 7.469727
| null | null | null | 5
| 7
|
<2 mo. follow-up
| 7
|
69
| 44.05499
| 1
|
female
| 0
| 7
| 293
|
Colon Cancer
|
Cancer
| 0
| 16
|
>$50k
| 0
| 18,563
| 11,069.4688
| null | 8
|
white
| 12.898438
| 5
| 0.890991
| 0.751953
| 1
| 0
| 0
|
metastatic
| 1
| 0.7
|
no dnr
| 7
| 85
| 8.5
| 72
| 20
| 37.39844
| null | null | null | null | 140
| null | null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
|
70
| 72.15594
| 0
|
male
| 0
| 35
| 1,984
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
|
>$50k
| 26
| 187,014
| 95,392.75
| null | 27.25
|
white
| 24.699219
| 29
| 0.61792
| 0.512939
| 7
| 0
| 0
|
no
| 0.8
| 0.8
|
no dnr
| 35
| 75
| 17.296875
| 120
| 24
| 38.29688
| 257.5
| 2.599609
| 4.899414
| 0.699951
| 135
| 7.5
| null | null | null | null | null |
adl>=4 (>=5 if sur)
| 2.70459
|
71
| 45.56598
| 1
|
male
| 1
| 5
| 5
|
MOSF w/Malig
|
ARF/MOSF
| 3
| 18
|
$25-$50k
| 0
| 181,701
| 92,664.625
| null | 51
|
white
| 69.296875
| 133
| 0
| 0
| 39
| 0
| 0
|
yes
| null | null |
dnr after sadm
| 3
| 33
| 0.299988
| 140
| 33
| 38.5
| 129
| 2.299805
| 31.398438
| 4.799805
| 142
| 7.359375
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
|
72
| 41.95999
| 1
|
male
| 0
| 4
| 503
|
Lung Cancer
|
Cancer
| 1
| 16
|
>$50k
| 0
| 4,173
| 2,648.0977
| null | 3
|
white
| 13.398438
| 7
| 0.813965
| 0.600952
| 1
| 0
| 0
|
metastatic
| 0.95
| 0.8
|
no dnr
| 4
| 97
| 10.798828
| 88
| 20
| 36.39844
| 380.9375
| 3.799805
| 0.5
| 1.099854
| 133
| 7.479492
| null | null | null | null | null |
no(M2 and SIP pres)
| 2.179688
|
73
| 59.31
| 0
|
male
| 0
| 72
| 1,981
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 15
|
>$50k
| 26
| 538,692
| 301,788.5
| null | 32.5
|
white
| 37.796875
| 71
| 0.311951
| 0.198975
| 13
| 0
| 0
|
no
| 0.5
| 0.4
|
no dnr
| 72
| 60
| 19.398438
| 160
| 38
| 37.29688
| 113.32812
| 3.099609
| 13.099609
| 1.299805
| 142
| 7.509766
| null | null | null | null | 2
|
adl>=4 (>=5 if sur)
| 2
|
74
| 45.61499
| 1
|
female
| 1
| 44
| 44
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 3
| 16
|
>$50k
| 44
| 302,353
| 155,929.75
| null | 30.5
|
white
| 27.199219
| 55
| 0.5979
| 0.406982
| 1
| 0
| 0
|
no
| 0.3
| 0.25
|
dnr after sadm
| 41
| 57
| 13.599609
| 112
| 28
| 38.59375
| 134.4375
| 1.699951
| 1.5
| 0.899902
| 139
| 7.179688
| null | null | null | null | null |
<2 mo. follow-up
| 3.54541
|
75
| 65.98499
| 1
|
female
| 0
| 10
| 540
|
Colon Cancer
|
Cancer
| 1
| 12
| null | 0
| 18,980
| 9,559.2266
| null | 13.5
|
hispanic
| 11.099609
| 19
| 0.880981
| 0.730957
| 1
| 1
| 0
|
metastatic
| null | null |
no dnr
| 10
| 127
| 17.796875
| 96
| 26
| 38.89844
| 372
| 4.099609
| 0.299988
| 0.799927
| 140
| 7.399414
| null | null | null | 1
| null |
no(M2 and SIP pres)
| 1.1669
|
76
| 95.79199
| 1
|
female
| 1
| 19
| 19
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null | null | 44
| 74,764
| 36,613.2812
| null | 29
|
white
| 19.199219
| 18
| 0.610962
| 0.504883
| 1
| 0
| 1
|
no
| null | null |
dnr after sadm
| 16
| 88
| 11.599609
| 65
| 8
| 37.19531
| 360
| 2.599609
| null | 1.699951
| 147
| 7.419922
| null | null | null | null | null |
<2 mo. follow-up
| 5.941406
|
77
| 76.59094
| 1
|
male
| 0
| 8
| 142
|
Colon Cancer
|
Cancer
| 1
| 17
|
$11-$25k
| 0
| 7,137
| 4,350.3672
| null | 4.5
|
white
| 7.799805
| 6
| 0.896973
| 0.762939
| 1
| 0
| 0
|
metastatic
| null | null |
dnr after sadm
| 1
| 83
| 12.798828
| 76
| 18
| 38.29688
| 390.4375
| 4.099609
| 0.799927
| 0.799927
| 146
| 7.439453
| null | null | null | 1
| 2
| null | 2
|
78
| 68.10095
| 0
|
male
| 0
| 4
| 1,979
|
CHF
|
COPD/CHF/Cirrhosis
| 1
| 12
|
$11-$25k
| 0
| 9,586
| 5,151.0469
| null | 7
|
white
| 17.898438
| 33
| 0.873901
| 0.790894
| 1
| 0
| 0
|
no
| 0.9
| 0.7
|
no dnr
| 4
| 72
| 5.899414
| 80
| 18
| 36.79688
| null | null | null | 2.199707
| 137
| null | null | null | null | null | null |
no(M2 and SIP pres)
| 1.971924
|
79
| 78.85297
| 1
|
female
| 1
| 6
| 6
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| null | null | 37
| 39,420
| 20,195.5781
| null | 27
|
white
| 21.5
| 30
| 0.642944
| 0.541992
| 3
| 0
| 1
|
no
| null | null |
dnr after sadm
| 4
| 60
| 36.195313
| 112
| 11
| 36.59375
| 214.28125
| null | 1.099854
| 1.099854
| 137
| 7.419922
| null | null | null | null | null |
<2 mo. follow-up
| 4.947266
|
80
| 37.87
| 0
|
male
| 0
| 120
| 1,977
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null | null | 9
| 397,017
| 207,528.5
| null | 31
|
white
| 31.097656
| 48
| 0.703979
| 0.61499
| 14
| 0
| 0
|
no
| 0.1
| 0.001
|
no dnr
| 120
| 83
| 23.5
| 122
| 26
| 37.59375
| 257.5
| null | 3.099609
| 5.199219
| 134
| 7.379883
| null | null | null | null | null | null | 2.540039
|
81
| 74.90997
| 1
|
female
| 0
| 6
| 18
|
COPD
|
COPD/CHF/Cirrhosis
| 1
| 16
| null | 0
| 8,166
| 4,166.6992
| null | 8
|
white
| 15.599609
| 9
| 0.866943
| 0.779907
| 1
| 0
| 0
|
no
| 0.8
| 0.7
|
no dnr
| 6
| 106
| 11.398438
| 84
| 22
| 37
| 424
| null | null | 0.799927
| 142
| 7.399414
| null | null | null | 0
| 0
|
<2 mo. follow-up
| 0
|
82
| 31.702
| 0
|
female
| 0
| 49
| 1,973
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 0
| 14
| null | 0
| 231,119
| 101,867.938
| null | 15.5
|
black
| 20.097656
| 24
| 0.903931
| 0.837891
| 1
| 0
| 0
|
no
| 0.2
| 0.1
|
no dnr
| 49
| 77
| 7.699219
| 80
| 20
| 37.19531
| 490.4375
| 2.199707
| 2.699707
| 1.399902
| 127
| 7.489258
| null | null | null | 6
| 1
|
SIP>=30
| 1
|
83
| 54.93997
| 1
|
female
| 0
| 10
| 55
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 14
|
$11-$25k
| 0
| 27,561
| 15,429.6172
| null | 21
|
white
| 20.199219
| 22
| 0.885986
| 0.80896
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 10
| 55
| 6.199219
| 104
| 24
| 36.79688
| 504
| 3.599609
| 1.099854
| 0.799927
| 136
| 7.459961
| null | null | null | 1
| 0
|
<2 mo. follow-up
| 0
|
84
| 43.30197
| 1
|
male
| 1
| 39
| 39
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 3
| 14
|
under $11k
| 0
| 283,145
| 108,597.562
| null | 13.75
|
hispanic
| 23.597656
| 33
| 0.826904
| 0.716919
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 39
| 83
| 10
| 80
| 20
| 37
| null | 2.099609
| 13
| 1
| 130
| null | null | null | null | 3
| 2
|
<2 mo. follow-up
| 2
|
85
| 54.92999
| 1
|
female
| 0
| 8
| 50
|
Lung Cancer
|
Cancer
| 0
| 12
|
$25-$50k
| 0
| 15,392
| 7,098.3008
| null | 10
|
asian
| 22
| 25
| 0.625977
| 0.312988
| 1
| 0
| 0
|
metastatic
| null | null |
no dnr
| 8
| 143
| 10.699219
| 84
| 40
| 36.19531
| null | 3.299805
| null | 0.799927
| 135
| null | null | null | null | 1
| 0
|
<2 mo. follow-up
| 0
|
86
| 70.21497
| 1
|
male
| 0
| 7
| 173
|
Colon Cancer
|
Cancer
| 1
| 12
|
$11-$25k
| 0
| 8,442
| 5,144.7188
| null | 11.5
|
white
| 25.398438
| 27
| 0.653931
| 0.348999
| 1
| 1
| 0
|
metastatic
| 0.9
| 0.5
|
no dnr
| 7
| 117
| 10.199219
| 22
| 18
| 38
| null | 3.099609
| 0.699951
| 1.299805
| 137
| null | null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
|
87
| 67.09399
| 0
|
female
| 0
| 27
| 1,969
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 2
| 3
|
under $11k
| 0
| 71,992
| 37,093.125
| null | 17.5
|
black
| 23.199219
| 28
| 0.68689
| 0.518921
| 1
| 0
| 0
|
no
| null | null |
dnr after sadm
| 5
| 104
| 21.796875
| 82
| 20
| 37
| null | 2
| 6.599609
| 0.599976
| 135
| null | null | null | null | null | 1
| null | 1
|
88
| 65.05096
| 1
|
male
| 0
| 10
| 125
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 2
| 14
|
$25-$50k
| 0
| 14,944
| 9,489.5391
| null | 9
|
white
| 27.796875
| 36
| 0.5979
| 0.407959
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 10
| 77
| 12.099609
| 72
| 22
| 36.39844
| null | 2.5
| 21.699219
| 1.199951
| 130
| null | null | null | null | 0
| 2
| null | 2
|
89
| 69.34698
| 1
|
male
| 1
| 42
| 42
|
MOSF w/Malig
|
ARF/MOSF
| 2
| 18
| null | 0
| 433,684
| 214,329.25
| null | 38.25
|
asian
| 25.398438
| 27
| 0.492981
| 0.375
| 11
| 1
| 0
|
metastatic
| null | null |
no dnr
| 42
| 112
| 10.398438
| 125
| 14
| 36.5
| 274.25
| 3.799805
| 5.699219
| 1.099854
| 140
| 7.449219
| null | null | null | null | 4
|
<2 mo. follow-up
| 4
|
90
| 64.98798
| 1
|
female
| 0
| 4
| 33
|
Lung Cancer
|
Cancer
| 0
| null | null | 0
| 8,137
| 4,735.9922
| null | 9
|
white
| 18.296875
| 11
| 0.680908
| 0.385986
| 1
| 0
| 0
|
metastatic
| null | null |
no dnr
| 4
| 110
| 18.796875
| 80
| 20
| 36.39844
| null | null | null | 0.699951
| 134
| null | null | null | null | null | null |
<2 mo. follow-up
| 2.198731
|
91
| 80.62097
| 1
|
male
| 1
| 4
| 4
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null | null | 37
| 104,163
| 53,111.3125
| null | 38
|
white
| 35.898438
| 77
| 0.167999
| 0.084991
| 14
| 0
| 0
|
no
| null | null |
dnr after sadm
| 2
| 61
| 23
| 140
| 32
| 39.19531
| 75.54688
| 2.299805
| 1.5
| 1.899902
| 135
| 7.129883
| null | null | null | null | null |
<2 mo. follow-up
| 3.361816
|
92
| 72.172
| 1
|
male
| 1
| 12
| 12
|
Lung Cancer
|
Cancer
| 1
| null | null | 0
| 62,158
| 31,507.8125
| null | 25
|
white
| 34.195313
| 47
| 0.222992
| 0.023998
| 1
| 0
| 0
|
metastatic
| 0.5
| 0.25
|
no dnr
| 12
| 63
| 5.099609
| 140
| 36
| 36.5
| 176.65625
| 2.699707
| null | 1.099854
| 135
| 7.55957
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
|
93
| 53.06198
| 1
|
male
| 0
| 3
| 28
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| null |
under $11k
| 0
| 6,734
| 3,384.6172
| null | 4
|
white
| 19.296875
| 28
| 0.890991
| 0.817993
| 1
| 0
| 0
|
yes
| null | null |
dnr after sadm
| 1
| 77
| 10.898438
| 72
| 24
| 36.39844
| 280.9375
| 3.899902
| null | 0.799927
| 126
| 7.479492
| null | null | null | null | null |
<2 mo. follow-up
| 2.619141
|
94
| 52.50699
| 1
|
female
| 1
| 6
| 6
|
CHF
|
COPD/CHF/Cirrhosis
| 1
| 12
|
$11-$25k
| 0
| 20,735
| 11,022.1016
| null | 9
|
white
| 20.898438
| 24
| 0.884888
| 0.80896
| 1
| 1
| 0
|
no
| 0.6
| 0.2
|
dnr after sadm
| 6
| 67
| 8.5
| 88
| 20
| 36.59375
| null | 3.099609
| 0.699951
| 1.399902
| 129
| null | null | null | null | 6
| 7
|
<2 mo. follow-up
| 7
|
95
| 74.97095
| 1
|
male
| 0
| 19
| 259
|
Colon Cancer
|
Cancer
| 0
| null | null | 0
| 43,009
| 22,430.0625
| null | 12.333328
|
white
| 3.299805
| 26
| 0.928955
| 0.832886
| 1
| 0
| 0
|
metastatic
| 0.9
| 0.85
|
no dnr
| 19
| 91
| 6.799805
| 88
| 20
| 36.79688
| null | 4.599609
| 2.5
| 1.099854
| 142
| null | null | null | null | null | null | null | 1.91626
|
96
| 53.34998
| 1
|
male
| 0
| 52
| 126
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 17
|
>$50k
| 26
| 483,991
| 285,715.25
| null | 39
|
asian
| 40.5
| 71
| 0.286987
| 0.176971
| 9
| 0
| 0
|
no
| 0.5
| 0.2
|
no dnr
| 52
| 73
| 19.5
| 158
| 36
| 39.29688
| 187.5
| 3.599609
| 11.099609
| 2.699707
| 154
| 7.369141
| null | null | null | null | 6
| null | 6
|
97
| 89.58795
| 1
|
male
| 1
| 4
| 4
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| null | null | 100
| 19,238
| 9,710.9062
| null | 34
|
white
| 54.898438
| 80
| 0
| 0
| 1
| 0
| 0
|
metastatic
| null | null |
no dnr
| 4
| 33
| 13.699219
| 0
| 0
| 38.5
| 122
| 2.299805
| 0.5
| 1
| 130
| 7.289062
| null | null | null | null | null |
<2 mo. follow-up
| 5.568359
|
98
| 56.62399
| 1
|
male
| 0
| 11
| 559
|
Colon Cancer
|
Cancer
| 0
| 12
|
>$50k
| 0
| 27,408
| 15,270.6484
| null | 12
|
white
| 5.699219
| 12
| 0.928955
| 0.833984
| 1
| 0
| 0
|
metastatic
| null | null |
no dnr
| 11
| 116
| 8.199219
| 102
| 18
| 38.39844
| null | 4.299805
| 0.299988
| 1.199951
| 136
| null | null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
|
99
| 75.04199
| 1
|
male
| 0
| 6
| 123
|
Colon Cancer
|
Cancer
| 0
| 16
| null | 0
| 8,723
| 5,835.2305
| null | 16
|
hispanic
| 35.898438
| 47
| 0.35199
| 0.074997
| 1
| 0
| 0
|
metastatic
| null | null |
no dnr
| 6
| 123
| 16.296875
| 112
| 28
| 36
| 352.375
| 2.899902
| 1.699951
| 7.599609
| 134
| 7.479492
| null | null | null | null | null |
SIP>=30
| 2.249512
|
100
| 75.76196
| 0
|
male
| 0
| 21
| 1,962
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| null | null | 0
| 74,162
| 40,581
| null | 23.666656
|
white
| 22.699219
| 28
| 0.734985
| 0.652954
| 8
| 0
| 0
|
no
| 0.8
| 0.8
|
no dnr
| 21
| 68
| 16.597656
| 79
| 20
| 37.19531
| 132.71875
| null | null | 1.099854
| 132
| 7.489258
| null | null | null | 0
| null | null | 0.4948
|
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.